Defencath

taurolidine, heparin

Approval

ApplicationNDA 214520
Approval dateNov 15, 2023
Approval year2023
SponsorCormedix

FDA-approved use

To reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Defencath: